GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
MELA Sciences Inc (MELA) [hlAlert]

Rating:
Speculative Buy
MELA
down 96.55 %

MELA Sciences Inc (MELA) upgraded to Speculative Buy with price target $4 by WBB Securities

Posted on: Monday,  Sep 24, 2012  10:25 AM ET by WBB Securities

WBB Securities rated Speculative Buy MELA Sciences Inc (NASDAQ: MELA) on 09/24/2012, when the stock price was $33.40.
Since then, MELA Sciences Inc has lost 96.56% as of 08/27/2015's recent price of $1.15.
If you would have followed this WBB Securities's recommendation on MELA, you would have lost 96.55% of your investment in 1067 days.

Electro-Optical Sciences, Inc. (EOS) is a medical device company focused on the design and development of a non-invasive, point-of-care instrument to assist in the early diagnosis of melanoma. EOS's flagship product, MelaFind, features a hand-held imaging device that emits light of multiple wavelengths to capture images of suspicious pigmented skin lesions and extract data. The data is then analyzed against EOS's database of melanomas and benign lesions using its algorithms in order to provide information to the physician and produce a recommendation of whether the lesion should be biopsied.

Research from WBB Securities provides investment professionals with up-to-date, in-depth, accurate and insightful reporting of companies that specialize in biotechnology, medical devices and healthcare. Our goal is to provide independent, straight-forward and up-to-date research so you can make educated decisions about your investments.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/24/2012 10:25 AM Buy
None
33.40 40.00
as of 12/31/2012
1 Week down  -9.59 %
1 Month down  -20.79 %
3 Months down  -44.23 %
1 YTD down  -46.40 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/17/2010 9:25 AM Hold
None
27.70 20.00
3/25/2010 8:25 AM Sell
None
66.30 50.00
11/30/2009 11:25 AM Sell
None
102.50 72.50

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy